.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cervical spondylotic myelopathy is often considered a surgical condition because ongoing cord compression can produce neurological decline. However, a randomized study of patients with mild or moderate, nonprogressive or slowly progressive disease compared conservative management with surgery over two years. The trial did not show a clear overall advantage for surgery in the primary neurological and gait outcomes during that period. This result applies to a carefully selected population and should not be extrapolated to patients with rapidly progressive deficits, severe myelopathy or major functional deterioration. For HCPs, the study highlights the importance of clinical trajectory. A patient with stable mild disease may reasonably undergo close monitoring and nonoperative management, whereas progressive weakness, gait decline or significant cord dysfunction changes the risk-benefit balance. The study also emphasises that treatment choice should be individualised and revisited over time. For clinicians, structured follow-up is essential because a conservative pathway only remains safe while neurological status remains stable.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Cervical spondylotic myelopathy is often considered a surgical condition because ongoing cord compression can produce neurological decline. However, a randomized study of patients with mild or moderate, nonprogressive or slowly progressive disease compared conservative management with surgery over two years. The trial did not show a clear overall advantage for surgery in the primary neurological and gait outcomes during that period. This result applies to a carefully selected population and should not be extrapolated to patients with rapidly progressive deficits, severe myelopathy or major functional deterioration. For HCPs, the study highlights the importance of clinical trajectory. A patient with stable mild disease may reasonably undergo close monitoring and nonoperative management, whereas progressive weakness, gait decline or significant cord dysfunction changes the risk-benefit balance. The study also emphasises that treatment choice should be individualised and revisited over time. For clinicians, structured follow-up is essential because a conservative pathway only remains safe while neurological status remains stable.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
